Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
MediciNova logo — Focused on innovative small-molecule therapeutics, addressin...

MediciNova

Focused on innovative small-molecule therapeutics, addressing unmet medical needs with strategic alliances and a diversified clinical portfolio.

Founded 2000 Post-IPO Equity Total: $136.00M Biotechnology, Health and Wellness +1

General Information

Company Name MediciNova
Founded Year 2000
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with MediciNova. To contact MediciNova, visit medicinova.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MediciNova compare?

A PDF of MediciNova and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MediciNova soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MediciNova

MediciNova is a biopharmaceutical company established in 2000 with a focus on innovative small-molecule therapeutics. The company is committed to addressing unmet medical needs, primarily in the U.S. market, through a diversified clinical portfolio and strategic alliances with Japanese pharmaceutical firms. Their pipeline includes clinical-stage compounds targeting acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, interstitial cystitis, and solid tumor cancers. Their $20.00M Post-IPO Equity investment on 12 January 2021 was secured from 3D Investment Partners. MediciNova's emphasis on appealing commercial potential and robust patent claims makes it a compelling prospect for investors in the Biotechnology, Health and Wellness, and Pharmaceutical industries.

Business keywords: biopharmaceutical, small-molecule therapeutics, clinical portfolio, unmet medical needs, strategic alliances, Japanese pharmaceutical firms, innovative treatments, drug development, patent assets, acute exacerbations, multiple sclerosis, addiction treatment, neuropathic pain, interstitial cystitis, solid tumor cancers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $20.00M 1
3D Investment Partners
3D Investment Partners
12 Jan 2021
Post IPO Equity $40.00M -
13 Feb 2018
Post IPO Equity $20.00M 1
Aspire Capital Partners, LLC
Aspire Capital Partners, LLC
20 Aug 2012
Post IPO Equity $12.00M -
30 Jan 2007
Venture Round $44.00M 7
Dream Incubator Mizuho Securities Principal Investment China Development Industrial Bank (CDIB)
Dream Incubator, Mizuho Securities Principal Investment +5
01 Aug 2004

MediciNova Alternatives & Competitors

MediciNova vs
Centrexion Therapeutics Corp.
Centrexion Therapeutics Corp. United States

We aim to relieve the suffering associated with chronic pain by creating treatments that address the...

Venture round
23 employees
Biotechnology, Health Care

FAQ About MediciNova

Focused on innovative small-molecule therapeutics, addressing unmet medical needs with strategic alliances and a diversified clinical portfolio.
MediciNova was founded in 2000.
MediciNova operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on biopharmaceutical, small-molecule therapeutics, clinical portfolio and unmet medical needs.
MediciNova has completed 5 funding rounds, raising a total of $136.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to MediciNova include Centrexion Therapeutics Corp.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MediciNova and Centrexion Therapeutics Corp. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MediciNova, https://bouncewatch.com/company/medicinova, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout